SARS-CoV-2 polymerase

First, we do not know whether remdesivir has failed. Not by a long shot. The leaked draft document of a trial in China may or may not be real.

It is rare to find a mention of Giliead's remdesivir, arguably the most promising drug in the fight against coronavirus, without also hearing that it failed miserably in fighting Ebola.